Growth Metrics

Vivos (RDGL) Debt Ratio (2011 - 2023)

Vivos recorded quarterly Debt Ratio of 0.01 in Q3 2023, down 100.0% quarter-over-quarter from 2562.44 in Q3 2018.

Vivos' Debt Ratio history runs 9 years deep, the most recent figure standing at 0.01 for Q3 2023.

  • In Q3 2023, Debt Ratio changed N/A year-over-year to 0.01; the TTM figure through Sep 2023 stood at 0.01 (changed N/A YoY), while the FY2016 annual figure was 10.76, down 37.1% from the prior year.
  • Debt Ratio came in at 0.01 for Q3 2023 at Vivos, down from 2562.44 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.01 in Q3 2023 to a low of 0.01 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.31
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.32
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.31
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.04
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.25
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.27
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.18
10 Vivos - - -3,105.00 -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 0.01
Sep 30, 2018 2,562.44
Jun 30, 2018 641.13
Mar 31, 2018 58.39
Sep 30, 2017 12.99
Jun 30, 2017 1.02
Mar 31, 2017 15.30
Dec 31, 2016 10.76
Sep 30, 2016 4.30
Jun 30, 2016 20.56
Mar 31, 2016 4.20
Dec 31, 2015 17.11
Sep 30, 2015 32.57
Jun 30, 2015 1.89
Mar 31, 2015 115.47
Dec 31, 2014 48.94
Sep 30, 2014 3.31
Jun 30, 2014 6.89
Mar 31, 2014 1.59
Dec 31, 2013 1.73
Sep 30, 2013 2.66
Jun 30, 2013 2.87
Dec 31, 2012 0.03
Sep 30, 2012 0.04
Jun 30, 2012 0.13
Mar 31, 2012 0.18
Jun 30, 2011 0.04